Biohaven Ltd. (BHVN) is a publicly traded Healthcare sector company. As of August 25, 2026, BHVN trades at $14.08 with a market cap of $2.04B and a P/E ratio of -0.95. BHVN moved +2.59% today. Year to date, BHVN is +27.77%; over the trailing twelve months it is -5.65%. Its 52-week range spans $7.48 to $44.28. Analyst consensus is strong buy with an average price target of $18.78. Rallies surfaces BHVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Biohaven Ltd. (BHVN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BHVN moved +2.59% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $14.08 |
| Market Cap | $2.04B |
| P/E Ratio | -0.95 |
| EPS | $-14.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.28 |
| 52-Week Low | $7.48 |
| Volume | 1.78M |
| Avg Volume | 0 |
| Revenue (TTM) | $859.68M |
| Net Income | $-930.69M |
| Gross Margin | 85.63% |
12 analysts cover BHVN: 0 strong buy, 9 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.78.